We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

172 hedge funds and large institutions have $192M invested in Heron Therapeutics in 2025 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 57 increasing their positions, 52 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 16

10% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 52

1% more funds holding

Funds holding: 171 → 172 (+1)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

2.89% less ownership

Funds ownership: 86.17% → 83.28% (-2.9%)

29% less capital invested

Capital invested by funds: $272M → $192M (-$79.8M)

98% less call options, than puts

Call options by funds: $44K | Put options by funds: $2.68M

Holders
172
Holders Change
+1
Holders Change %
+0.58%
% of All Funds
2.26%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
19
Increased
57
Reduced
52
Closed
16
Calls
$44K
Puts
$2.68M
Net Calls
-$2.64M
Net Calls Change
-$5.83M

Top Buyers

Rank Fund Capital Flow
1
CC
Clearline Capital
New York
+$14M
2
BBA
Baker Bros. Advisors
New York
+$6.74M
3
Citigroup
Citigroup
New York
+$3.84M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$3.78M
5
RCMNY
Rubric Capital Management (New York)
New York
+$3.78M

Top Sellers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
-$6.23M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$4.45M
3
Marshall Wace
Marshall Wace
United Kingdom
-$2.51M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$1.7M
5
JFG
Jefferies Financial Group
New York
-$1.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
FFWM
151
Future Financial Wealth Management
Ohio
$4.41K – – –
Optiver Holding
152
Optiver Holding
Netherlands
$2.37K -$2 -1 -0.1%
EWA
153
EverSource Wealth Advisors
Alabama
$2.2K +$2.46K +1,550 +795%
NEWAS
154
N.E.W. Advisory Services
Wisconsin
$2.04K – – –
Bessemer Group
155
Bessemer Group
New Jersey
$2K – – –
AF
156
Allworth Financial
California
$1.96K +$2.41K +1,519 +4,340%
SPIA
157
Steward Partners Investment Advisory
New York
$1.26K – – –
WAS
158
Winch Advisory Services
Wisconsin
$1.26K – – –
ASN
159
Advisory Services Network
Georgia
$958 +$1.21K +760 New
IA
160
IFP Advisors
Florida
$650 +$764 +482 +1,418%
CB
161
CNB Bank
Pennsylvania
$630 – – –
FC
162
Financial Consulate
Maryland
$630 +$793 +500 New
NECFA
163
New England Capital Financial Advisors
Connecticut
$599 – – –
SIC
164
SJS Investment Consulting
Ohio
$504 – – –
PA
165
Parallel Advisors
California
$252 – – –
AF
166
Advisornet Financial
Minnesota
$139 – – –
EWM
167
Evermay Wealth Management
Virginia
$126 – – –
HWM
168
HighMark Wealth Management
Minnesota
$126 – – –
FFO
169
Fortitude Family Office
Arizona
$112 – – –
Rockefeller Capital Management
170
Rockefeller Capital Management
New York
$77 +$97 +61 New
RIL
171
Rothschild Investment LLC
Illinois
$40 -$322 -203 -86%
SS
172
SBI Securities
Japan
$1 -$2 -1 -50%
ACM
173
AIGH Capital Management
Maryland
– -$6.23M -3,009,257 Closed
Jacobs Levy Equity Management
174
Jacobs Levy Equity Management
New Jersey
– -$1.7M -820,504 Closed
JFG
175
Jefferies Financial Group
New York
– -$1.38M -666,800 Closed
4 5 6
7
8

HRTX Hedge Fund Activity: Q3 2025 in Review

172 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q3 2025, worth a combined $192M — down 29% from $272M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new HRTX positions and 16 closed out — a net gain of 3 holders — while 57 added to existing stakes and 52 trimmed.

The largest buyer was Clearline Capital, adding an estimated $14M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $6.23M sold.

  • 172 institutional investors held Heron Therapeutics (HRTX) as of Q3 2025, up from 171 in Q2 2025.
  • Funds reported $192M of Heron Therapeutics stock for Q3 2025, down 29% quarter-over-quarter.
  • 19 funds opened new Heron Therapeutics positions in Q3 2025 and 16 closed out, a net change of +3 holders.
  • The largest Heron Therapeutics buyer in Q3 2025 was Clearline Capital, an estimated $14M added.
  • The largest Heron Therapeutics seller in Q3 2025 was AIGH Capital Management, an estimated $6.23M sold.

Based on aggregated 13F filings for Q3 2025.